{"schema_version":"secwatch.filing_event.v1","accession":"0001486957-26-000041","form_type":"8-K","ticker":"BWXT","cik":"0001486957","company_name":"BWX Technologies, Inc.","filed_at":"2026-08-03T20:28:58+00:00","discovered_at":"2026-08-03T20:30:00.408548+00:00","generated_at":"2026-08-03T20:30:05.191684+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"BWXT Q2 revenue $901.6M (+18% YoY), GAAP EPS $0.97, raises FY2026 guidance","bullets":["Q2 revenue $901.6M (+18% YoY); Government Ops $601.3M (+2%), Commercial Ops $302.5M (+72%).","GAAP net income $89.1M ($0.97 diluted EPS); non-GAAP EPS $1.07, adjusted EBITDA $155.5M (+7%).","Announced sale of medical business to focus on nuclear national defense and commercial power.","Closed acquisition of Precision Components Group on July 1, 2026, adding U.S. commercial nuclear manufacturing.","Raised FY2026 guidance: adjusted EBITDA $662M-$672M, non-GAAP EPS $4.70-$4.80, FCF $345M-$360M."],"urls":{"canonical":"https://secwatch.observer/filing/0001486957-26-000041","json":"https://secwatch.observer/filing/0001486957-26-000041.json","markdown":"https://secwatch.observer/filing/0001486957-26-000041.md","text":"https://secwatch.observer/filing/0001486957-26-000041.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1486957/000148695726000041/0001486957-26-000041-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1486957/000148695726000041/bwxt_63026x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-03T20:30:05.191684+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}